Medeon Biodesign
2012
FOUNDED
PUBLIC
STATUS
6499
STOCK SYMBOL
2
INVESTMENTS
$2.10
SHARE PRICE
(As of Friday Closing)
Description
Medeon Biodesign Inc develops medical device products. It is developing devices for invasive surgeries and for treating diseases including cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, & nephrology. The company provides products in fields of cardiovascular and laparoscopic.
Primary Industry
Surgical Devices
Stock Exchange
ROCO
Primary Office
- 116, HouGang Street
- 7th Floor
- Taipei, 111-70
- Taiwan
+886 02 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Medeon Biodesign’s full profile, request a free trial.
Medeon Biodesign Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.89 - $2.89 | $140M | $2.02 | -$0.11 | 64.4K | 66.5M |
Medeon Biodesign Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 89,065 | 113,440 | 109,155 | 175,824 |
| Revenue | 13,299 | 22,326 | 5,405 | 904 |
| EBITDA | (4,909) | 8,821 | (7,548) | (6,439) |
| Net Income | (7,134) | 8,506 | (8,119) | (6,749) |
| Total Assets | 82,411 | 63,675 | 55,192 | 55,284 |
| Total Debt | 3,917 | 1 | 186 | 271 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Medeon Biodesign Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Medeon Biodesign‘s full profile, request access.
Request full access to PitchBookMedeon Biodesign Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000000000 | 31-May-2019 | 000000000 | Therapeutic Devices | ||
| Panther Orthopedics | 28-Mar-2018 | Corporate | Therapeutic Devices | 000-000 0000 00.0 |
Medeon Biodesign Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Yue-Teh Jang Ph.D | Founder, Chairman, President & Chief Executive Officer | ||
| Shuling Cheng Ph.D | Chief Strategy Officer |
Medeon Biodesign Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Yue-Teh Jang Ph.D | Medeon Biodesign | Founder, Chairman, President & Chief Executive Officer | 000 0000 |